Short-term low calorie diet intervention reduces serum advanced glycation end products in healthy overweight or obese adults

Annals of Nutrition and Metabolism

Volumn 54, Issue 3, 2009, Pages 197-201

  Gugliucci, Alejandro ^a   Kotani, Kazuhiko ^b   Taing, Jennifer ^a   Matsuoka, Yukiyo ^b   Sano, Yoshiko ^b   Yoshimura, Makiko ^c   Egawa, Kahori ^c   Horikawa, Chika ^c   Kitagawa, Yoshinori ^c   Kiso, Yoshinobu ^c   Kimura, Satoshi ^d   Sakane, Naoki ^b  

^a TOURO UNIVERSITY CALIFORNIA   (United States)

^b NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^c SUNTORY LTD   (Japan)

^d SHOWA UNIVERSITY NORTHERN YOKOHAMA HOSPITAL   (Japan)

Author keywords

Advanced glycation; Body mass index; Caloric restriction; Weight reduction

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CARBOHYDRATE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CALORIC RESTRICTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; JAPANESE; LOW CALORY DIET; MALE; MEAL; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CALORIC RESTRICTION; DIET RECORDS; DIET, REDUCING; FEMALE; FOOD, FORMULATED; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LIPIDS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; STATISTICS, NONPARAMETRIC; WAIST CIRCUMFERENCE; WEIGHT LOSS;

EID: 65449141734     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000217817     Document Type: Article

References (21)

1. Haffner SM: Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. Obesity 2006;14:S121-S127.
2. Shin MJ, Hyun YJ, Kim OY, Kim JY, Jang Y, Lee JH: Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes 2006;30:1529-1534.
3. Monnier VM, Kohn RR, Cerami A: Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci USA 1984;81:583-587.
4. Dyer DG, Blackledge JA, Thorpe SR, Baynes JW: Formation of pentosidine during non- enzymatic browning of proteins by glucose: identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J Biol Chem 1991; 266:11654-11660.
5. Csiszar A, Ungvari ZI: Endothelial dysfunction and vascular inflammation in type II diabetes: interaction of AGE/RAGE and TNF-α signaling. Am J Physiol Heart Circ Physiol 2008; 295:H475-H476.
6. Soro-Paavonen A, Watson AM, Li J, Paavonen K, Koitka A, Calkin AC: Rage deficiency attenuates the development of atherosclerosis in diabetes. Diabetes 2008; 57: 2461-2469.
7. Gugliucci A, Bendayan M: Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catab- olism of AGE-peptides by renal proximal tubular cells. Diabetologia 1996; 39:149-160.
8. Rabbani N, Sebekova K, Sebekova K, Heidland A, Thornalley PJ: Accumulation of free adduct glycation, oxidation, and nitration products follows acute loss of renal function. Kidney Int 2007;72:1113-1121.
9. Vlassara H, Striker G: Glycotoxins in the diet promote diabetes and diabetic complications. Curr Diab Rep 2007; 7: 235-241.
10. Uribarri J, Peppa M, Cai W, Goldberg T, Lu M, He C, Vlassara H: Restriction of dietary glycotoxins reduces excessive advanced gly- cation end products in renal failure patients. J Am Soc Nephrol 2003; 14:728-731.
11. Diamanti-Kandarakis E, Katsikis I, Piperi C, Alexandraki K, Panidis D: Effect of long- term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome. Clin Endo-crinol (Oxf) 2007;66: 103-109.
12. Li SY, Liu Y, Sigmon VK, McCort A, Ren J: High-fat diet enhances visceral advanced glycation end products, nuclear O-Glc-Nac modification, p38 mitogen-activated protein kinase activation and apoptosis. Diabetes Obes Metab 2005; 7: 448-454.
13. Hill JO, Wyatt H: Outpatient management of obesity: a primary care perspective. Obes Res 2002; 2:S124-S130.
14. Berkel LA, Poston WS, Reeves RS, Foreyt JP: Behavioral interventions for obesity. J Am Diet Assoc 2005; 105:S35-S43.
15. Barnard RJ: Effects of life-style modification on serum lipids. Arch Intern Med 1991; 151: 1389-1394.
16. Gugliucci A, Mehlhaff K, Kinugasa E, Ogata H, Hermo R, Schulze J, Kimura S: Paraox- onase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance. Clin Chim Acta 2007;377:213-220.
17. Clynes R, Moser B, Yan SF, Ramasamy R, Herold K, Schmidt AM: Receptor for AGE (RAGE): weaving tangled webs within the inflammatory response. Curr Mol Med 2007; 7: 743-751.
18. Norata GD, Garlaschelli K, Grigore L, Tibol- la G, Raselli S, Redaelli L: Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population. Nutr Metab Cardiovasc Dis 2008; 19: 129-139. DOI: 10.1016/j.numecd.2008.03. 004.
19. Vander Jagt DL: Methylglyoxal, diabetes mellitus and diabetic complications. Drug Metabol Drug Interact 2008;23:93-124.
20. Cai W, He JC, Zhu L, Chen X, Zheng F, Striker GE, Vlassara H: Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. Am J Pathol 2008; 173: 327-336.
21. Januszewski AS, Jenkins AJ, Baynes JW, Thorpe SR: Lipid-derived modifications of plasma proteins in experimental and human diabetes. Ann NY Acad Sci 2005; 1043: 404-412.